WINDWARD BIO GROUP AG

SEC 4 · Filed

0000947871-26-001038Accepted

Applies to the EDGAR acceptance time.

Other time zone
Insider transactionsEvent date Nov 16, 2026

Exercise or conversion by ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC

Security
Warrants (right to buy)
Code
M
Shares
216,668
Price per share
0.00
Structured facts
{
  "code": "M",
  "date": "2026-11-16",
  "direction": "D",
  "exercise_price": "0.02",
  "expiration": "2036-05-12",
  "footnotes": {
    "F2": "These securities are held of record by OrbiMed Private Investments IX, LP (\"OPI IX\"). OrbiMed Capital GP IX LLC (\"GP IX\") is the general partner of OPI IX. OrbiMed Advisors LLC (\"OrbiMed Advisors\"), a registered investment adviser under the Investment Advisers Act of 1940, as amended, is the managing member of GP IX. By virtue of such relationships, GP IX and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by OPI IX. OrbiMed Advisors exercises this investment and voting power through a management committee comprised of Carl L. Gordon, W. Carter Neild, and Geoffrey C. Hsu, each of whom disclaims beneficial ownership of the shares held by OPI IX.",
    "F3": "This report on Form 4 is jointly filed by OrbiMed Advisors and GP IX. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of its pecuniary interest therein, if any. The Reporting Persons have designated David P. Bonita, a member of OrbiMed Advisors, to serve on the Issuer\u0027s board of directors. This report shall not be deemed an admission that any of such entity or person is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.",
    "F5": "The exercise price is in US Dollars and reflects the conversion of CHF to USD at an exchange rate of $1.2151 to CHF 1.00 as of October 30, 2026, as approved by the Issuer\u0027s board of directors.",
    "F7": "The warrants are fully vested and exercisable."
  },
  "owners": [
    {
      "cik": "0001055951",
      "name": "ORBIMED ADVISORS LLC",
      "roles": [
        "director",
        "ten_percent_owner"
      ],
      "title": null
    },
    {
      "cik": "0001920574",
      "name": "OrbiMed Capital GP IX LLC",
      "roles": [
        "director",
        "ten_percent_owner"
      ],
      "title": null
    }
  ],
  "ownership": "I",
  "post_shares": "0",
  "price": "0",
  "row": 3,
  "rule_10b5_1": "0",
  "security": "Warrants (right to buy)",
  "shares": "216668",
  "table": "II",
  "underlying_security": "Common Shares",
  "underlying_shares": "216668"
}
Insider transactionsEvent date Nov 16, 2026

Conversion by ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC

Security
Series B Preferred Shares
Code
C
Shares
1,611,008
Price per share
0.00
Structured facts
{
  "code": "C",
  "date": "2026-11-16",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F2": "These securities are held of record by OrbiMed Private Investments IX, LP (\"OPI IX\"). OrbiMed Capital GP IX LLC (\"GP IX\") is the general partner of OPI IX. OrbiMed Advisors LLC (\"OrbiMed Advisors\"), a registered investment adviser under the Investment Advisers Act of 1940, as amended, is the managing member of GP IX. By virtue of such relationships, GP IX and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by OPI IX. OrbiMed Advisors exercises this investment and voting power through a management committee comprised of Carl L. Gordon, W. Carter Neild, and Geoffrey C. Hsu, each of whom disclaims beneficial ownership of the shares held by OPI IX.",
    "F3": "This report on Form 4 is jointly filed by OrbiMed Advisors and GP IX. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of its pecuniary interest therein, if any. The Reporting Persons have designated David P. Bonita, a member of OrbiMed Advisors, to serve on the Issuer\u0027s board of directors. This report shall not be deemed an admission that any of such entity or person is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.",
    "F4": "Each Series A Preferred Share and Series B Preferred Share automatically converted into the number of Common Shares on a 1-to-1 basis immediately prior to the closing of the Issuer\u0027s initial public offering and has no expiration date."
  },
  "owners": [
    {
      "cik": "0001055951",
      "name": "ORBIMED ADVISORS LLC",
      "roles": [
        "director",
        "ten_percent_owner"
      ],
      "title": null
    },
    {
      "cik": "0001920574",
      "name": "OrbiMed Capital GP IX LLC",
      "roles": [
        "director",
        "ten_percent_owner"
      ],
      "title": null
    }
  ],
  "ownership": "I",
  "post_shares": "0",
  "price": "0",
  "row": 2,
  "rule_10b5_1": "0",
  "security": "Series B Preferred Shares",
  "shares": "1611008",
  "table": "II",
  "underlying_security": "Common Shares",
  "underlying_shares": "1611008"
}
Insider transactionsEvent date Nov 16, 2026

Conversion by ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC

Security
Series A Preferred Shares
Code
C
Shares
3,561,936
Price per share
0.00
Structured facts
{
  "code": "C",
  "date": "2026-11-16",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F2": "These securities are held of record by OrbiMed Private Investments IX, LP (\"OPI IX\"). OrbiMed Capital GP IX LLC (\"GP IX\") is the general partner of OPI IX. OrbiMed Advisors LLC (\"OrbiMed Advisors\"), a registered investment adviser under the Investment Advisers Act of 1940, as amended, is the managing member of GP IX. By virtue of such relationships, GP IX and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by OPI IX. OrbiMed Advisors exercises this investment and voting power through a management committee comprised of Carl L. Gordon, W. Carter Neild, and Geoffrey C. Hsu, each of whom disclaims beneficial ownership of the shares held by OPI IX.",
    "F3": "This report on Form 4 is jointly filed by OrbiMed Advisors and GP IX. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of its pecuniary interest therein, if any. The Reporting Persons have designated David P. Bonita, a member of OrbiMed Advisors, to serve on the Issuer\u0027s board of directors. This report shall not be deemed an admission that any of such entity or person is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.",
    "F4": "Each Series A Preferred Share and Series B Preferred Share automatically converted into the number of Common Shares on a 1-to-1 basis immediately prior to the closing of the Issuer\u0027s initial public offering and has no expiration date."
  },
  "owners": [
    {
      "cik": "0001055951",
      "name": "ORBIMED ADVISORS LLC",
      "roles": [
        "director",
        "ten_percent_owner"
      ],
      "title": null
    },
    {
      "cik": "0001920574",
      "name": "OrbiMed Capital GP IX LLC",
      "roles": [
        "director",
        "ten_percent_owner"
      ],
      "title": null
    }
  ],
  "ownership": "I",
  "post_shares": "0",
  "price": "0",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Series A Preferred Shares",
  "shares": "3561936",
  "table": "II",
  "underlying_security": "Common Shares",
  "underlying_shares": "3561936"
}
Insider transactionsEvent date Nov 16, 2026

Payment of exercise price or tax by delivery of securities by ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC

Security
Common Shares
Code
F
Shares
232
Price per share
17.00
Structured facts
{
  "code": "F",
  "date": "2026-11-16",
  "direction": "D",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F2": "These securities are held of record by OrbiMed Private Investments IX, LP (\"OPI IX\"). OrbiMed Capital GP IX LLC (\"GP IX\") is the general partner of OPI IX. OrbiMed Advisors LLC (\"OrbiMed Advisors\"), a registered investment adviser under the Investment Advisers Act of 1940, as amended, is the managing member of GP IX. By virtue of such relationships, GP IX and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by OPI IX. OrbiMed Advisors exercises this investment and voting power through a management committee comprised of Carl L. Gordon, W. Carter Neild, and Geoffrey C. Hsu, each of whom disclaims beneficial ownership of the shares held by OPI IX.",
    "F3": "This report on Form 4 is jointly filed by OrbiMed Advisors and GP IX. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of its pecuniary interest therein, if any. The Reporting Persons have designated David P. Bonita, a member of OrbiMed Advisors, to serve on the Issuer\u0027s board of directors. This report shall not be deemed an admission that any of such entity or person is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.",
    "F6": "Reflects Common Shares withheld in connection with the Reporting Person\u0027s exercise of warrants."
  },
  "owners": [
    {
      "cik": "0001055951",
      "name": "ORBIMED ADVISORS LLC",
      "roles": [
        "director",
        "ten_percent_owner"
      ],
      "title": null
    },
    {
      "cik": "0001920574",
      "name": "OrbiMed Capital GP IX LLC",
      "roles": [
        "director",
        "ten_percent_owner"
      ],
      "title": null
    }
  ],
  "ownership": "I",
  "post_shares": "7097483",
  "price": "17.00",
  "row": 5,
  "rule_10b5_1": "0",
  "security": "Common Shares",
  "shares": "232",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Nov 16, 2026

Exercise or conversion by ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC

Security
Common Shares
Code
M
Shares
216,668
Price per share
0.02
Structured facts
{
  "code": "M",
  "date": "2026-11-16",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F2": "These securities are held of record by OrbiMed Private Investments IX, LP (\"OPI IX\"). OrbiMed Capital GP IX LLC (\"GP IX\") is the general partner of OPI IX. OrbiMed Advisors LLC (\"OrbiMed Advisors\"), a registered investment adviser under the Investment Advisers Act of 1940, as amended, is the managing member of GP IX. By virtue of such relationships, GP IX and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by OPI IX. OrbiMed Advisors exercises this investment and voting power through a management committee comprised of Carl L. Gordon, W. Carter Neild, and Geoffrey C. Hsu, each of whom disclaims beneficial ownership of the shares held by OPI IX.",
    "F3": "This report on Form 4 is jointly filed by OrbiMed Advisors and GP IX. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of its pecuniary interest therein, if any. The Reporting Persons have designated David P. Bonita, a member of OrbiMed Advisors, to serve on the Issuer\u0027s board of directors. This report shall not be deemed an admission that any of such entity or person is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.",
    "F5": "The exercise price is in US Dollars and reflects the conversion of CHF to USD at an exchange rate of $1.2151 to CHF 1.00 as of October 30, 2026, as approved by the Issuer\u0027s board of directors."
  },
  "owners": [
    {
      "cik": "0001055951",
      "name": "ORBIMED ADVISORS LLC",
      "roles": [
        "director",
        "ten_percent_owner"
      ],
      "title": null
    },
    {
      "cik": "0001920574",
      "name": "OrbiMed Capital GP IX LLC",
      "roles": [
        "director",
        "ten_percent_owner"
      ],
      "title": null
    }
  ],
  "ownership": "I",
  "post_shares": "7097715",
  "price": "0.02",
  "row": 4,
  "rule_10b5_1": "0",
  "security": "Common Shares",
  "shares": "216668",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Nov 16, 2026

Conversion by ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC

Security
Common Shares
Code
C
Shares
1,611,008
Price per share
Unreported
Structured facts
{
  "code": "C",
  "date": "2026-11-16",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F2": "These securities are held of record by OrbiMed Private Investments IX, LP (\"OPI IX\"). OrbiMed Capital GP IX LLC (\"GP IX\") is the general partner of OPI IX. OrbiMed Advisors LLC (\"OrbiMed Advisors\"), a registered investment adviser under the Investment Advisers Act of 1940, as amended, is the managing member of GP IX. By virtue of such relationships, GP IX and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by OPI IX. OrbiMed Advisors exercises this investment and voting power through a management committee comprised of Carl L. Gordon, W. Carter Neild, and Geoffrey C. Hsu, each of whom disclaims beneficial ownership of the shares held by OPI IX.",
    "F3": "This report on Form 4 is jointly filed by OrbiMed Advisors and GP IX. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of its pecuniary interest therein, if any. The Reporting Persons have designated David P. Bonita, a member of OrbiMed Advisors, to serve on the Issuer\u0027s board of directors. This report shall not be deemed an admission that any of such entity or person is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.",
    "F4": "Each Series A Preferred Share and Series B Preferred Share automatically converted into the number of Common Shares on a 1-to-1 basis immediately prior to the closing of the Issuer\u0027s initial public offering and has no expiration date."
  },
  "owners": [
    {
      "cik": "0001055951",
      "name": "ORBIMED ADVISORS LLC",
      "roles": [
        "director",
        "ten_percent_owner"
      ],
      "title": null
    },
    {
      "cik": "0001920574",
      "name": "OrbiMed Capital GP IX LLC",
      "roles": [
        "director",
        "ten_percent_owner"
      ],
      "title": null
    }
  ],
  "ownership": "I",
  "post_shares": "6881047",
  "price": null,
  "row": 3,
  "rule_10b5_1": "0",
  "security": "Common Shares",
  "shares": "1611008",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Nov 16, 2026

Conversion by ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC

Security
Common Shares
Code
C
Shares
3,561,936
Price per share
Unreported
Structured facts
{
  "code": "C",
  "date": "2026-11-16",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F2": "These securities are held of record by OrbiMed Private Investments IX, LP (\"OPI IX\"). OrbiMed Capital GP IX LLC (\"GP IX\") is the general partner of OPI IX. OrbiMed Advisors LLC (\"OrbiMed Advisors\"), a registered investment adviser under the Investment Advisers Act of 1940, as amended, is the managing member of GP IX. By virtue of such relationships, GP IX and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by OPI IX. OrbiMed Advisors exercises this investment and voting power through a management committee comprised of Carl L. Gordon, W. Carter Neild, and Geoffrey C. Hsu, each of whom disclaims beneficial ownership of the shares held by OPI IX.",
    "F3": "This report on Form 4 is jointly filed by OrbiMed Advisors and GP IX. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of its pecuniary interest therein, if any. The Reporting Persons have designated David P. Bonita, a member of OrbiMed Advisors, to serve on the Issuer\u0027s board of directors. This report shall not be deemed an admission that any of such entity or person is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose.",
    "F4": "Each Series A Preferred Share and Series B Preferred Share automatically converted into the number of Common Shares on a 1-to-1 basis immediately prior to the closing of the Issuer\u0027s initial public offering and has no expiration date."
  },
  "owners": [
    {
      "cik": "0001055951",
      "name": "ORBIMED ADVISORS LLC",
      "roles": [
        "director",
        "ten_percent_owner"
      ],
      "title": null
    },
    {
      "cik": "0001920574",
      "name": "OrbiMed Capital GP IX LLC",
      "roles": [
        "director",
        "ten_percent_owner"
      ],
      "title": null
    }
  ],
  "ownership": "I",
  "post_shares": "5270039",
  "price": null,
  "row": 2,
  "rule_10b5_1": "0",
  "security": "Common Shares",
  "shares": "3561936",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}
Insider transactionsEvent date Nov 16, 2026

Purchase by ORBIMED ADVISORS LLC, OrbiMed Capital GP IX LLC

Security
Common Shares
Code
P
Shares
1,176,471
Price per share
17.00
Structured facts
{
  "code": "P",
  "date": "2026-11-16",
  "direction": "A",
  "exercise_price": null,
  "expiration": null,
  "footnotes": {
    "F1": "Reflects Common Shares of the Issuer purchased in the Issuer\u0027s initial public offering.",
    "F2": "These securities are held of record by OrbiMed Private Investments IX, LP (\"OPI IX\"). OrbiMed Capital GP IX LLC (\"GP IX\") is the general partner of OPI IX. OrbiMed Advisors LLC (\"OrbiMed Advisors\"), a registered investment adviser under the Investment Advisers Act of 1940, as amended, is the managing member of GP IX. By virtue of such relationships, GP IX and OrbiMed Advisors may be deemed to have voting and investment power with respect to the securities held by OPI IX. OrbiMed Advisors exercises this investment and voting power through a management committee comprised of Carl L. Gordon, W. Carter Neild, and Geoffrey C. Hsu, each of whom disclaims beneficial ownership of the shares held by OPI IX.",
    "F3": "This report on Form 4 is jointly filed by OrbiMed Advisors and GP IX. Each of the Reporting Persons disclaims beneficial ownership of the securities reported herein for purposes of Rule 16a-1(a) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\"), except to the extent of its pecuniary interest therein, if any. The Reporting Persons have designated David P. Bonita, a member of OrbiMed Advisors, to serve on the Issuer\u0027s board of directors. This report shall not be deemed an admission that any of such entity or person is a beneficial owner of such securities for purposes of Section 16 of the Exchange Act, or for any other purpose."
  },
  "owners": [
    {
      "cik": "0001055951",
      "name": "ORBIMED ADVISORS LLC",
      "roles": [
        "director",
        "ten_percent_owner"
      ],
      "title": null
    },
    {
      "cik": "0001920574",
      "name": "OrbiMed Capital GP IX LLC",
      "roles": [
        "director",
        "ten_percent_owner"
      ],
      "title": null
    }
  ],
  "ownership": "I",
  "post_shares": "1708103",
  "price": "17.00",
  "row": 1,
  "rule_10b5_1": "0",
  "security": "Common Shares",
  "shares": "1176471",
  "table": "I",
  "underlying_security": null,
  "underlying_shares": null
}